URITOS Tablets are contraindicated in the following patients: Patients with urinary retention (symptoms may be aggravated due to inhibition of bladder contraction during urination caused by the anticholinergic effect of this product).
Patients with occluded pyloric region/duodenum/intestine or paralytic ileus (symptoms may be aggravated due to inhibition of contraction and motility of gastrointestinal smooth muscles caused by the anticholinergic effect of this product).
Patients with decreased gastrointestinal movements and muscular tension (symptoms may be aggravated due to inhibition of contraction and motility of gastrointestinal smooth muscles caused by the anticholinergic effect of this product).
Patients with narrow-angle glaucoma (symptoms may be aggravated due to an increase in intraocular pressure caused by the anticholinergic effect of this product).
Patients with myasthenia gravis (symptoms may be aggravated due to a decrease in muscle tone caused by the anticholinergic effect of this product).
Patients with severe heart disease (symptoms may be aggravated since abnormal electrocardiographic findings including extra systoles have been reported).
Patients with a history of hypersensitivity to any of the components of this product.
Sign Out